Matilda Biotech: Announcement on the progress of share repurchases
Matilda Biotech: 2024 Interim Equity Distribution Implementation Notice
Matilda Biotech: Announcement on the progress of share repurchases
Matilda Biotech: Announcement on the repurchase ratio of the company\'s shares reaching 4% and the progress of the repurchase
Matilda Biotech: Announcement on the progress of share repurchases
Matilda Biotech: Announcement on the 2024 Mid-Term Profit Distribution Plan
Wuhan Easy Diagnosis Biomedicine: Short-form equity change report (Wang Ying, Wang Rui)
Wuhan Easy Diagnosis Biomedicine: Simplified Equity Change Report (Chen Lili)
Wuhan Easy Diagnosis Biomedicine: Announcement regarding the progress of share buyback.
Wuhan Easy Diagnosis Biomedicine: Announcement regarding the progress of share buyback.
Wuhan Easy Diagnosis Biomedicine: Announcement on the Implementation Results of Share Repurchase for Maintaining Company Value and Shareholders' Rights and Interests and Changes in Shareholding
Wuhan Easy Diagnosis Biomedicine: Announcement on the progress of the repurchase of company shares reaching 3%.
Wuhan Easy Diagnosis Biomedicine: Announcement regarding the progress of share buyback.
Wuhan Easy Diagnosis Biomedicine: 2023 Annual Equity Distribution Implementation Notice
Wuhan Easy Diagnosis Biomedicine: Announcement on the repurchase ratio of the company's shares reaching 2% and the progress of the repurchase
Wuhan Easy Diagnosis Biomedicine: Announcement on the progress of share repurchases
Wuhan Easy Diagnosis Biomedicine: Announcement on the 2023 Profit Distribution Plan
Wuhan Easy Diagnosis Biomedicine: Announcement on Authorizing the Board of Directors to Formulate Interim Dividend Plans
Matilda Biotech: Announcement on the repurchase ratio of the company's shares reaching 1% and the progress of the repurchase
Matilda Biotech: Announcement on the progress of share repurchases
No Data
No Data